Financials data is unavailable for this security.
View more
Year on year NuGen Medical Devices Inc had net income fall 67.84% from a loss of 5.58m to a larger loss of 9.36m despite a 117.51% increase in revenues from 152.36k to 331.40k. An increase in the cost of goods sold as a percentage of sales from 34.91% to 50.26% was a component in the falling net income despite rising revenues.
| Gross margin | 49.15% |
|---|---|
| Net profit margin | -2,201.37% |
| Operating margin | -1,713.80% |
| Return on assets | -100.85% |
|---|---|
| Return on equity | -- |
| Return on investment | -152.05% |
More ▼
Cash flow in CADView more
In 2023, NuGen Medical Devices Inc increased its cash reserves by 253.34%, or 333.01k. Cash Flow from Financing totalled 7.10m or 2,142.59% of revenues. In addition the company used 6.71m for operations while cash used for investing totalled 53.40k.
| Cash flow per share | -0.0347 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.0172 |
|---|---|
| Tangible book value per share | -0.0417 |
More ▼
Balance sheet in CADView more
| Current ratio | 0.4159 |
|---|---|
| Quick ratio | 0.1734 |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | 1.83 |
More ▼
